Literature DB >> 28804551

A tumor-suppressive microRNA, miRNA-485-5p, inhibits glioma cell proliferation and invasion by down-regulating TPD52L2.

Jin Yu1,2, Shi-Wen Wu2, Wei-Ping Wu1.   

Abstract

Glioblastoma multiforme is the most deadly primary brain tumor and has no effective treatment. Therefore, it is important to identify novel and effective therapies that impede glioma tumorigenesis. MicroRNAs (miRNAs) are helpful analytical biomarkers and may be useful targets for treating multiple human cancers. Previous reports suggest that miRNA-485-5p is dysregulated and contributes to tumorigenesis in some cancer types. Nevertheless, the biological role of miRNA-485-5p in glioma is not well understood. In this study, we demonstrated that miRNA-485-5p expression was reduced in gliomat issues and cell lines. In addition, miRNA-485-5p overexpression inhibited cell proliferation, migration, and invasion in glioma cell lines. Additionally, we identified Tumor Protein D52 Like 2 (TPD52L2) as a direct target of miRNA-485-5p. Moreover, we showed that miRNA-485-5p regulated glioma tumorigenesis by down-regulating TPD52L2 expression in vitro and in vivo. Our results suggest that miRNA-485-5p is a suppressor of glioma tumorigenesis and could serve as a novel candidate for therapeutic applications in glioma treatment.

Entities:  

Keywords:  glioma; invasion; miR-485-5p; proliferation; tumorigenesis

Year:  2017        PMID: 28804551      PMCID: PMC5553883     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  28 in total

Review 1.  The emerging roles of microRNAs in cancer metabolism.

Authors:  Brian Chan; Jacob Manley; Jae Lee; Shree Ram Singh
Journal:  Cancer Lett       Date:  2015-01-28       Impact factor: 8.679

Review 2.  MicroRNA as potential modulators in chemoresistant high-grade gliomas.

Authors:  Sharon Yin Yee Low; Yoon Khei Ho; Heng-Phon Too; Celestial Therese Yap; Wai Hoe Ng
Journal:  J Clin Neurosci       Date:  2013-10-06       Impact factor: 1.961

3.  Tumor protein D52-like 2 accelerates gastric cancer cell proliferation in vitro.

Authors:  Jiapeng Xu; Weimin Wang; Zhenxin Zhu; Ziran Wei; Dejun Yang; Qingping Cai
Journal:  Cancer Biother Radiopharm       Date:  2015-03-06       Impact factor: 3.099

4.  Prognostic value of Musashi-1 in gliomas.

Authors:  Rikke H Dahlrot; Steinbjørn Hansen; Jørn Herrstedt; Henrik D Schrøder; Jacob Hjelmborg; Bjarne W Kristensen
Journal:  J Neurooncol       Date:  2013-09-21       Impact factor: 4.130

5.  MicroRNA-485-5p suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting stanniocalcin 2.

Authors:  Guo-Xiao Guo; Quan-Ying Li; Wan-Li Ma; Zhao-Hui Shi; Xue-Qun Ren
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 6.  MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.

Authors:  Shan Muhammad; Kavanjit Kaur; Rui Huang; Qian Zhang; Paviter Kaur; Hamza Obaid Yazdani; Muhammad Umar Bilal; Jiang Zheng; Liu Zheng; Xi-Shan Wang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 7.  MicroRNAs as diagnostic and prognostic biomarkers in colorectal cancer.

Authors:  Rui Yi; Yao Li; Fei-Liang Wang; Gang Miao; Ruo-Mei Qi; Yan-Yang Zhao
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

8.  miR-485-5p acts as a negative regulator in gastric cancer progression by targeting flotillin-1.

Authors:  Min Kang; Mei-Ping Ren; Lei Zhao; Chang-Ping Li; Ming-Ming Deng
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

Review 9.  Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy.

Authors:  Kirk E Cahill; Ramin A Morshed; Bakhtiar Yamini
Journal:  Neuro Oncol       Date:  2015-11-02       Impact factor: 12.300

Review 10.  MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics.

Authors:  Amanda Shea; Varsha Harish; Zainab Afzal; Juliet Chijioke; Habib Kedir; Shahnoza Dusmatova; Arpita Roy; Malathi Ramalinga; Brent Harris; Jan Blancato; Mukesh Verma; Deepak Kumar
Journal:  Cancer Med       Date:  2016-06-10       Impact factor: 4.452

View more
  6 in total

1.  Hydrogen sulfide alleviates myocardial fibrosis in mice with alcoholic cardiomyopathy by downregulating autophagy.

Authors:  Biao Liang; Ting Xiao; Junrong Long; Maojun Liu; Zining Li; Shengquan Liu; Jun Yang
Journal:  Int J Mol Med       Date:  2017-10-16       Impact factor: 4.101

2.  Reduced levels of miR-485-5p in HPV-infected cervical cancer promote cell proliferation and enhance invasion ability.

Authors:  Yuanyuan Dai; Fengyan Xie; Yan Chen
Journal:  FEBS Open Bio       Date:  2020-06-30       Impact factor: 2.693

3.  MicroRNA-485-5p suppresses the proliferation, migration and invasion of small cell lung cancer cells by targeting flotillin-2.

Authors:  Feng Gao; Hao Wu; Rui Wang; Yang Guo; Zefeng Zhang; Tao Wang; Guoliang Zhang; Changjiang Liu; Junfeng Liu
Journal:  Bioengineered       Date:  2019-12       Impact factor: 3.269

4.  MicroRNA‑485‑5p suppresses the progression of esophageal squamous cell carcinoma by targeting flotillin‑1 and inhibits the epithelial‑mesenchymal transition.

Authors:  Riyang Zhao; Yanan Shan; Xinliang Zhou; Cong Zhang; Ruinian Zhao; Lianmei Zhao; Baoen Shan
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

5.  Rapamycin Inhibits Glioma Cells Growth and Promotes Autophagy by miR-26a-5p/DAPK1 Axis.

Authors:  Zheng Wang; Xiaoxi Wang; Fei Cheng; Xue Wen; Shi Feng; Fang Yu; Hui Tang; Zhengjin Liu; Xiaodong Teng
Journal:  Cancer Manag Res       Date:  2021-03-22       Impact factor: 3.989

6.  The Antitumor Effect of TPD52L2 Silencing on Oxaliplatin-Resistant Gastric Carcinoma Is Related to Endoplasmic Reticulum Stress In Vitro.

Authors:  Yu Zhang; Dejun Yang; Ziran Wei; Xin Zhang; Zunqi Hu; Hongbing Fu; Jiapeng Xu; Weijun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-01-18       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.